Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Cardiology · Rheumatic Pericarditis

Fighting the Fire: Treating Active Inflammation

At a Glance

Rheumatic pericarditis is treated by clearing the streptococcal trigger with penicillin, calming inflammation with prescribed medicines, and monitoring blood tests and heart ultrasounds. Severe cases may need steroids or urgent hospital care.

Medication Safety Warning: Never start, combine, or stop anti-inflammatory medications or antibiotics based on this guide. High-dose NSAIDs, colchicine, and corticosteroids carry significant risks involving bleeding, kidney/liver disease, drug interactions, pregnancy, and stomach ulcers. Always follow your treating physician’s specific instructions, and seek urgent care if you experience severe medication side effects, such as signs of allergic reaction, severe stomach pain, or black/tarry stools.

Treating rheumatic pericarditis is a two-front battle. Your care team must address the immediate “fire” of active inflammation in the heart while also eliminating the underlying trigger—the strep bacteria—to prevent future attacks. Because this condition is an immune overreaction, the goal of treatment is to calm the immune system before it causes permanent damage to your heart valves [1][2]. Note that outpatient anti-inflammatory treatment is for uncomplicated cases; if you develop severe shortness of breath or fainting, you may have an emergency like cardiac tamponade that requires urgent hospital treatment and fluid drainage.

Step 1: Stopping the Trigger (Antibiotics)

Even if your throat swab is currently negative, the first step in treating an acute rheumatic flare-up is usually a course of antibiotics, typically penicillin. This ensures that any current Group A Streptococcus bacteria are completely eradicated from your throat [3][4]. Note that this antibiotic course does not reverse the immune process that has already begun in your heart.

Once the initial infection is cleared, if you have a confirmed ARF or RHD diagnosis, you will transition to secondary prophylaxis. This involves long-term, regular doses of penicillin (often an injection every 3–4 weeks) to prevent a new strep infection from re-triggering your immune system and causing more heart damage [5][6].

Step 2: Calming the Inflammation

To manage the sharp chest pain of pericarditis and the overall inflammation of the heart, doctors use potent anti-inflammatory medications.

  • Aspirin or NSAIDs: High-dose aspirin has traditionally been the first-choice treatment for acute rheumatic fever [2][7]. If aspirin isn’t tolerated or causes side effects like liver irritation or stomach upset, other NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) like ibuprofen or naproxen may be used as alternatives [8][9].
  • Colchicine: This medication is often used to treat idiopathic or viral pericarditis. In other types of heart sac inflammation, colchicine has been shown to cut the risk of the inflammation returning by about 50% [10][11]. While there is less specific data for rheumatic cases, some cardiologists use it to help resolve effusions (fluid) and stabilize the heart sac [12][13].

Step 3: Managing Severe Cases (Corticosteroids)

If the inflammation is severe—specifically if it involves significant valve damage (carditis) or heart failure—your doctor may prescribe corticosteroids such as prednisone [14][7].

Corticosteroids are powerful tools, but they come with a “caution” flag. If they are stopped too quickly, the inflammation can “bounce back,” a phenomenon known as a rebound flare [10]. Because of this, steroids must be tapered (reduced very slowly) over several weeks or months while your doctor monitors your symptoms and blood tests [14].

Step 4: Advanced Options for Recurrent Pain

In rare cases where the pericarditis keeps coming back despite standard treatment (recurrent pericarditis), doctors may look at specialized “biologic” therapies.

  • IL-1 Inhibitors: Medications like anakinra or rilonacept block a specific protein in the immune system called Interleukin-1, which is a major driver of heart sac inflammation [15][16].
  • These are currently more common for “idiopathic” (unknown cause) pericarditis, but they are an important area of research for difficult cases [17][18].

Monitoring Your Recovery

Your doctor will use “markers of inflammation” to see how well you are responding to treatment.

  • CRP and ESR: These blood tests measure the level of “fire” in your system. As you recover, these numbers should drop toward a normal range [19][13].
  • Echocardiograms: Regular ultrasounds will check if any fluid around the heart is disappearing and ensure your heart valves are staying healthy [20][21].

Recovery is a gradual process. Tapering your medications is a careful process that requires your doctor to assess your pain levels, blood tests, and overall heart function to ensure it is safe to proceed [16][19].

Common questions in this guide

How is rheumatic pericarditis treated?
Treatment usually has two goals: clear any remaining Group A Streptococcus with penicillin and reduce inflammation around the heart with medicines such as aspirin or another NSAID. Severe heart involvement may require prednisone, and long-term penicillin prophylaxis may be recommended after confirmed acute rheumatic fever or rheumatic heart disease.
Why might I need penicillin if my throat test is negative?
A negative throat swab does not necessarily mean there is no need to treat a preceding or current strep infection. A penicillin course is usually used to eradicate any remaining Group A Streptococcus, but it does not undo the immune inflammation already affecting the heart. People with confirmed acute rheumatic fever or rheumatic heart disease may then need regular penicillin prophylaxis to prevent new attacks.
Which medicines can reduce inflammation from rheumatic pericarditis?
High-dose aspirin is traditionally used for acute rheumatic fever, with ibuprofen or naproxen used if aspirin is not tolerated. Colchicine may be considered in some cases, although evidence is less specific for rheumatic pericarditis. Prednisone or another corticosteroid may be used when inflammation is severe or there is significant carditis or heart failure.
Why must prednisone be tapered instead of stopped suddenly?
Prednisone and other corticosteroids usually need to be reduced gradually rather than stopped suddenly. Stopping too quickly can allow inflammation to return as a rebound flare. Your clinician may use your symptoms, blood tests, and heart-function checks to decide the tapering schedule.
How will my doctor know whether treatment is working?
CRP and ESR are blood tests that help show whether inflammation is falling. Echocardiograms can show whether fluid around the heart is resolving and whether the heart valves remain healthy. Doctors also consider symptoms such as pain, breathing, energy, and overall heart function.
When is rheumatic pericarditis an emergency?
Severe shortness of breath or fainting during pericarditis can signal a dangerous buildup of fluid around the heart called cardiac tamponade. These symptoms require urgent medical assessment, often in a hospital, where fluid drainage may be needed.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on the severity of my heart involvement (carditis), do I need corticosteroids like prednisone, or are NSAIDs sufficient?
  2. 2.What is the exact schedule for my penicillin injections, and how do we ensure they happen every 21 to 28 days without fail?
  3. 3.If we use high-dose aspirin, how will we monitor for side effects like stomach irritation or liver changes?
  4. 4.How will you decide when it is safe to start 'tapering' (slowly reducing) my anti-inflammatory medications?
  5. 5.Given that I have pericarditis, should we add colchicine to help prevent the inflammation from coming back?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    Acute Rheumatic Fever and Rheumatic Heart Disease: Highlighting the Role of Group A Streptococcus in the Global Burden of Cardiovascular Disease.

    Auala T, Zavale BG, Mbakwem AÇ, Mocumbi AO

    Pathogens (Basel, Switzerland) 2022; (11(5)) doi:10.3390/pathogens11050496.

    PMID: 35631018
  2. 2

    Acute Rheumatic Fever: Case Report and Literature Review.

    Noguchi K, Arain N, Galloway C

    South Dakota medicine : the journal of the South Dakota State Medical Association 2022; (75(5)):212-215.

    PMID: 35724350
  3. 3

    Sydenham's Chorea as the Sole Presenting Symptom of Acute Rheumatic Fever in a 14-Year-Old Boy: A Case Report.

    Nashwan O, Elmezayen ZW, Alrabadi B, et al.

    Clinical medicine insights. Case reports 2026; (19()):11795476261437634 doi:10.1177/11795476261437634.

    PMID: 42051599
  4. 4

    Delayed Diagnosis of Acute Rheumatic Fever in a Patient with Multiple Emergency Department Visits.

    Kaminecki I, Verma R, Brunetto J, Rivera LI

    Case reports in pediatrics 2018; (2018()):9467131 doi:10.1155/2018/9467131.

    PMID: 29974004
  5. 5

    Acute rheumatic fever and rheumatic heart disease among children--American Samoa, 2011-2012.

    Beaudoin A, Edison L, Introcaso CE, et al.

    MMWR. Morbidity and mortality weekly report 2015; (64(20)):555-8.

    PMID: 26020139
  6. 6

    Implementing the World Health Organization Guidelines for Rheumatic Heart Disease in Highly Endemic Settings: Balancing Evidence with Reality.

    Ali SKM

    Global heart 2026; (21(1)):9 doi:10.5334/gh.1527.

    PMID: 41726857
  7. 7

    Anti-inflammatory treatment for carditis in acute rheumatic fever.

    Cilliers A, Adler AJ, Saloojee H

    The Cochrane database of systematic reviews 2015; CD003176 doi:10.1002/14651858.CD003176.pub3.

    PMID: 26017576
  8. 8

    Aspirin-induced hepatotoxicity and anemia in children with acute rheumatic fever.

    Altay D, Pamukçu Ö, Baykan A, et al.

    The Turkish journal of pediatrics 2021; (63(2)):193-199.

    PMID: 33929108
  9. 9

    [Acute rheumatic fever (ARF) in an adult male].

    Usme MMN, Bublak A, Atmowihardjo I, Spencker S

    Innere Medizin (Heidelberg, Germany) 2022; (63(9)):990-993 doi:10.1007/s00108-022-01357-1.

    PMID: 35925118
  10. 10

    Evaluation and Treatment of Pericarditis: A Systematic Review.

    Imazio M, Gaita F, LeWinter M

    JAMA 2015; (314(14)):1498-506 doi:10.1001/jama.2015.12763.

    PMID: 26461998
  11. 11

    A systematic review and meta-analysis of randomized controlled trials evaluating pharmacologic therapies for acute and recurrent pericarditis.

    Melendo-Viu M, Marchán-Lopez Á, Guarch CJ, et al.

    Trends in cardiovascular medicine 2023; (33(5)):319-326 doi:10.1016/j.tcm.2022.02.001.

    PMID: 35131416
  12. 12

    Suspected acute rheumatic fever in a young man in England.

    Wilson ZM, Craster K

    BMJ case reports 2021; (14(11)) doi:10.1136/bcr-2021-244469.

    PMID: 34753720
  13. 13

    Colchicine ameliorates the chronic inflammatory state in patients with chronic rheumatic valvular heart disease: a pilot study.

    Rifaie O, Badr M, Salam AA, Galal H

    The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology 2020; (72(1)):42 doi:10.1186/s43044-020-00080-2.

    PMID: 32676868
  14. 14

    Outcome following acute and recurrent rheumatic fever.

    Silvilairat S, Sornwai A, Sethasathien S, et al.

    Paediatrics and international child health 2024; (44(1)):13-17 doi:10.1080/20469047.2024.2313330.

    PMID: 38363075
  15. 15

    Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial.

    Brucato A, Imazio M, Gattorno M, et al.

    JAMA 2016; (316(18)):1906-1912 doi:10.1001/jama.2016.15826.

    PMID: 27825009
  16. 16

    Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis.

    Klein AL, Imazio M, Cremer P, et al.

    The New England journal of medicine 2021; (384(1)):31-41 doi:10.1056/NEJMoa2027892.

    PMID: 33200890
  17. 17

    Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study.

    Imazio M, Andreis A, De Ferrari GM, et al.

    European journal of preventive cardiology 2020; (27(9)):956-964 doi:10.1177/2047487319879534.

    PMID: 31610707
  18. 18

    RHAPSODY: Rationale for and design of a pivotal Phase 3 trial to assess efficacy and safety of rilonacept, an interleukin-1α and interleukin-1β trap, in patients with recurrent pericarditis.

    Klein AL, Imazio M, Brucato A, et al.

    American heart journal 2020; (228()):81-90 doi:10.1016/j.ahj.2020.07.004.

    PMID: 32866928
  19. 19

    Red blood cell distribution width: can it be a predictive marker for long-term valvular involvement in children with acute rheumatic carditis?

    Kucuk M, Ozdemir R, Karadeniz C, et al.

    International journal of laboratory hematology 2016; (38(5)):569-75 doi:10.1111/ijlh.12544.

    PMID: 27435353
  20. 20

    Global Longitudinal Strain and Biomarker Dynamics in Children With Acute Rheumatic Fever and Mitral Regurgitation: A 12-Month Prospective Study.

    Çelik SF, Karagoz U

    Cureus 2025; (17(11)):e97492 doi:10.7759/cureus.97492.

    PMID: 41446443
  21. 21

    An evidence-based scoring system to diagnose acute rheumatic fever with carditis in children.

    Narang R, Saxena A, Ramakrishnan S, et al.

    International journal of cardiology 2021; (333()):146-151 doi:10.1016/j.ijcard.2021.02.084.

    PMID: 33667575

This page is for informational purposes only and does not constitute medical advice about rheumatic pericarditis. Follow your clinician's instructions before taking, changing, or stopping antibiotics or anti-inflammatory medicines.

Get notified when new evidence is published on chronic rheumatic pericarditis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.